With Chronic Stable Angina. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). JACC 1999; 33: 2092-2197. p align="justify">. ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Web Version. p align="justify">. ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines). A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). JACC 2001; 37: 2239i-2239lxvi. p align="justify">. S. Levy, G. Breithardt, R. Campbell et al.on behalf of the Working Group on Arrhythias of the European Society of Cardiology. Atrial fibrillation: current knowledge and recommendations for management. Eur Heart J 1998; 19: 1294-1320. p align="justify">. G. Albers, J. Dalen, A. Laupacis et.al. Antithrombotic Therapy in Atrial Fibrillation. Chest 2001; 119: 194S-206S. p align="justify">. G. Frostfeldt, G. Ahlberg, G. Gustafsson et al. Low Molecular Weight Heparin (Dalteparin) as Adjuvant Treatment to Thrombolysis in Acute Myocardial Infarction - A Pilot Study: Biochemical Markers of Acute Coronary Syndromes (BIOMACS II). JACC 1999; 33: 627-633. p align="justify">. F. Kontny, J. Dale, U. Abildgaard et al. Randomized trial of low molecular weight heparin (dalteparin) in prevention of left ventricular thrombus formation and arterial embolism after acute anterior myocardial infarction: the Fragmin in Acute Myocardial Infarction (FRAMI) Study. JACC 1997; 39: 962-969. p align="justify">. S. Baird, S. McBride, T. Trouton, C. Wilson. Low Molecular Weight Heparin Versus Unfractionated Heparin Following Thrombolysis in Myocardial Infarction. JACC 1998; 31 (suppl. 2A): 191A. p align="justify">. A. Glick, R. Kornowski, Y. Michowich et al. Reduction of reinfarction and angina with use of low-molecular-weight heparin therapy after streptokinase (and heparin) in acute myocardial infarction. Am J Cardiol 1996; 77: 1145-1148. p align="justify">. A. Ross, P. Molhoek, C. Lundergan et al. Randomized Comparison of Enoxaparin Low-Molecular-Weight Heparin With Unfractionated Hepfrin Adjunctive to Recombinant Tissue Plasminogen Activator Thrombolysis and Aspirin Second Trial of Hepfrin and Aspirin Reperfusion Therapy (HART II). Circulation 2001; 104: 648-652. p align="justify">. I. Menown, S. Baird, S. McBride et al. Evaluation of low-molecular-weight heparin in patients receiving fibrinolytic therapy for myocardial infarction. Eur Heart J 2000; 21 (abstr.suppl.): 599. p align="justify">. L. Wallentin, D. Dellborg, B. Nilsson et al. The Low-Molec...
